CLSU - BSED/Biology Major Fermentation/Autoclave/Microscope/Protozoa etc. By: Mark Alvin Lazaro … Continue reading →

Biology Project 2014 Chelsea Brown via YouTube Capture. By: Chelsea Brown … Continue reading →

Biology Morphology of Flowering Plants part 27 (Flower types) CBSE class 11 XI Biology Morphology of Flowering Plants part 27 (Flower types: Hypogynous, Epigynous, Perigynous, Trimerous, Pentamerous, Tetramerous) CBSE class 11 XI. By: ExamFearVideos … Continue reading →

Biology Ecology Video Assignment E2 2013 Biology assignment semester 1 . By: Farhan Hil Me … Continue reading →

Raw Interview: QU Associate Professor of Biology Joe Coehlo The Iowa Wildlife Federation released a report this week putting the blame of the increase in ticks and mosquitoes - on climate change. We checked in with a professor of biological science... By: KHQA … Continue reading →

Management, Resources and Reproductive Biology (WMSCI 2014) "Management, Resources and Reproductive Biology" (Special Track on Knowledge Integration and Inter-Disciplinary Communication - WMSCI 2014) Prof. Bernard Wallner University of Vienna, Austria... By: IIISchannel … Continue reading →

Image courtesy of Thinkstock. The 21st Century has seen technology contribute life-altering realities like getting from New York to Beijing in less than 14 hours or grandparents using Facetime to see their newly anointed Princes and Princesses of future generations. New technologies have not only democratized widespread access of information worldwide, it has created new ways of providing cheaper and better products to improve quality of life. Yet with all the advancements made, healthcare continues to operate through an outdated and archaic paradigm. To be fair, a number of new discoveries have been made through technologies such as next-gen sequencing, high-throughput screening processes, and robotics however they continue to be used on the same hypothesis-driven, chemical screening platform from 30 years ago. Why are we screening chemicals first and looking to biology last? Most drugs developed today are on the market for years before we can even fully grasp their impact or effect. Simply put, we fail to engage the biology upfront in the process. Considering that on average it takes roughly $1.7 billion and 12-14 years to bring a single drug to market, this is a costly proposition. And our healthcare system is buckling under this burden. The very … Continue reading →

UCCs Centre for Research in Vascular Biology has developed a device that promotes the bypass of arterial obstructions, potentially removing the need for major surgery. Worldwide, there are approximately three million open heart coronary bypass and peripheral artery bypass operations each year. These procedures involve major surgery with inherent risks of anaesthesia, ventilation, surgical trauma and potential complications, such as kidney failure and wound infection. Around 20% of all patients requiring surgery are unable to undergo such bypass procedures because of the poor status of their arteries or co-existing illness that would make the risk of surgery too great. Publishing in the latest issue of the prestigious journal Biomaterials, the research project (led by Professor Noel Caplice in UCC with collaborators in the Mayo Clinic, USA) has developed a vascular cell delivery device and tested it successfully in a large animal model with similar sized arteries to humans. The device is inserted via a keyhole procedure through the artery to the site of obstruction and promotes micro-bypass of this obstruction over a four week period. This results in the return of normal heart function and a recovery of full exercise capacity. Professor Noel Caplice, director of the Centre for Research … Continue reading →